Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 pituitary hormone (growth hormone) preparation vs somatropin in Japan
jRCT2080224776Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2 trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by Novo Nordisk. Started Jul 2019; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on jRCT2080224776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224776.